ÌÇÐÄÆƽâ°æ

Leading companies in the U.S. based on generics market share in 2023

© ÌÇÐÄÆƽâ°æ 2026
Download
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Release date

February 2024

Region

United States

Survey time period

2023

Supplementary notes

This statistic describes market share based on generic non-discounted spending. Moving annual total (MAT) December 2023.

Citation formats

Generics market share of top corporations in the U.S. 2023

Published by A. Minhas, Nov 25, 2024

In 2023, Teva was the leading generic drug company in the United States, with a market share of nearly percent in 2023. This statistic depicts the leading generic drug corporations in the U.S. in 2023 (MAT December), by revenue through non-discounted spending.

Log in or register to access precise data.
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

  • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 99 users
Talk to sales for pricing
Contact us
  • Free + Premium Statistics
  • Reports
  • Market ÌÇÐÄÆƽâ°æ

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " Generics and biosimilars in the U.S. "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Generics and biosimilars in the U.S.

Global Overview & Context

6

Competitive Landscape

5

Market Penetration & Entry Pipeline

5

Pricing & Payer Economics

6

Biosimilar Market Acceleration

6

Further Content: You might find this interesting as well

Topics

TevaGlobal pharmaceutical industryPharmaceutical industry in the U.S.Top pharmaceutical drugsPfizer
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

  • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 99 users
Talk to sales for pricing
Contact us
  • Free + Premium Statistics
  • Reports
  • Market ÌÇÐÄÆƽâ°æ

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.